These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 38906550

  • 1. Inhibition of receptor interacting protein kinase-1 (RIPK1) in the treatment of murine lupus.
    Peng L, Wang P, Xu X, Chen D, Xu F, Yang F, Yang S, Xia H, Liu ZH, Qin W.
    Lupus Sci Med; 2024 Jun 21; 11(1):. PubMed ID: 38906550
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-9 Is Associated with Elevated Anti-Double-Stranded DNA Antibodies in Lupus-Prone Mice.
    Yang J, Li Q, Yang X, Li M.
    Mol Med; 2015 Apr 15; 21(1):364-70. PubMed ID: 25902303
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
    Dang WZ, Li H, Jiang B, Nandakumar KS, Liu KF, Liu LX, Yu XC, Tan HJ, Zhou C.
    Phytomedicine; 2019 Sep 15; 62():152965. PubMed ID: 31129432
    [Abstract] [Full Text] [Related]

  • 4. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
    Lichtnekert J, Rupanagudi KV, Kulkarni OP, Darisipudi MN, Allam R, Anders HJ.
    J Immunol; 2011 Sep 15; 187(6):3413-21. PubMed ID: 21849682
    [Abstract] [Full Text] [Related]

  • 5. Amiselimod (MT-1303), a Novel Sphingosine 1-Phosphate Receptor-1 Modulator, Potently Inhibits the Progression of Lupus Nephritis in Two Murine SLE Models.
    Sugahara K, Maeda Y, Shimano K, Murase M, Mochiduki S, Takemoto K, Kakimoto T, Utsumi H, Oshita K, Kataoka H.
    J Immunol Res; 2019 Sep 15; 2019():5821589. PubMed ID: 31930150
    [Abstract] [Full Text] [Related]

  • 6. Interleukin-25 is upregulated in patients with systemic lupus erythematosus and ameliorates murine lupus by inhibiting inflammatory cytokine production.
    Li Y, Wang R, Liu S, Liu J, Pan W, Li F, Li J, Meng D.
    Int Immunopharmacol; 2019 Sep 15; 74():105680. PubMed ID: 31200339
    [Abstract] [Full Text] [Related]

  • 7. Depletion of autoreactive plasma cells and treatment of lupus nephritis in mice using CEP-33779, a novel, orally active, selective inhibitor of JAK2.
    Lu LD, Stump KL, Wallace NH, Dobrzanski P, Serdikoff C, Gingrich DE, Dugan BJ, Angeles TS, Albom MS, Mason JL, Ator MA, Dorsey BD, Ruggeri BA, Seavey MM.
    J Immunol; 2011 Oct 01; 187(7):3840-53. PubMed ID: 21880982
    [Abstract] [Full Text] [Related]

  • 8. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H, Hirata D, Kamimura T, Sato H, Iwamoto M, Yoshio T, Masuyama J, Fujimura A, Kobayashi E, Kano S, Minota S.
    J Rheumatol; 2002 Apr 01; 29(4):707-16. PubMed ID: 11950011
    [Abstract] [Full Text] [Related]

  • 9. IL-33 neutralization suppresses lupus disease in lupus-prone mice.
    Li P, Lin W, Zheng X.
    Inflammation; 2014 Jun 01; 37(3):824-32. PubMed ID: 24398614
    [Abstract] [Full Text] [Related]

  • 10. BTK inhibition ameliorates kidney disease in spontaneous lupus nephritis.
    Chalmers SA, Glynn E, Garcia SJ, Panzenbeck M, Pelletier J, Dimock J, Seccareccia E, Bosanac T, Khalil S, Harcken C, Webb D, Nabozny G, Fine JS, Souza D, Klein E, Herlitz L, Ramanujam M, Putterman C.
    Clin Immunol; 2018 Dec 01; 197():205-218. PubMed ID: 30339790
    [Abstract] [Full Text] [Related]

  • 11. Beneficial effect of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil on survival and severity of glomerulonephritis in systemic lupus erythematosus (SLE)-prone MRLlpr/lpr mice.
    Jonsson CA, Svensson L, Carlsten H.
    Clin Exp Immunol; 1999 Jun 01; 116(3):534-41. PubMed ID: 10361247
    [Abstract] [Full Text] [Related]

  • 12. Pim-1 as a Therapeutic Target in Lupus Nephritis.
    Fu R, Xia Y, Li M, Mao R, Guo C, Zhou M, Tan H, Liu M, Wang S, Yang N, Zhao J.
    Arthritis Rheumatol; 2019 Aug 01; 71(8):1308-1318. PubMed ID: 30791224
    [Abstract] [Full Text] [Related]

  • 13. Niclosamide suppresses the expansion of follicular helper T cells and alleviates disease severity in two murine models of lupus via STAT3.
    Jang SG, Lee J, Hong SM, Song YS, Kim MJ, Kwok SK, Cho ML, Park SH.
    J Transl Med; 2021 Feb 25; 19(1):86. PubMed ID: 33632240
    [Abstract] [Full Text] [Related]

  • 14. Targeting the Protective Arm of the Renin-Angiotensin System to Reduce Systemic Lupus Erythematosus Related Pathologies in MRL-lpr Mice.
    Soto M, Delatorre N, Hurst C, Rodgers KE.
    Front Immunol; 2020 Feb 25; 11():1572. PubMed ID: 32793221
    [Abstract] [Full Text] [Related]

  • 15. The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis.
    Liao W, Zheng H, Wu S, Zhang Y, Wang W, Zhang Z, Zhou C, Wu H, Min J.
    Am J Nephrol; 2017 Feb 25; 46(5):371-379. PubMed ID: 29069649
    [Abstract] [Full Text] [Related]

  • 16. Anti-ANX A1 Antibody Therapy in MRL/lpr Murine Model of Systemic Lupus Erythematosus.
    Bradyanova S, Mihaylova N, Chipinski P, Manassiev Y, Herbáth M, Kyurkchiev D, Prechl J, Tchorbanov AI.
    Arch Immunol Ther Exp (Warsz); 2021 Jul 28; 69(1):19. PubMed ID: 34322760
    [Abstract] [Full Text] [Related]

  • 17. Heat shock protein 90 inhibition by 17-DMAG lessens disease in the MRL/lpr mouse model of systemic lupus erythematosus.
    Shimp SK, Chafin CB, Regna NL, Hammond SE, Read MA, Caudell DL, Rylander M, Reilly CM.
    Cell Mol Immunol; 2012 May 28; 9(3):255-66. PubMed ID: 22543833
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of EZH2 Ameliorates Lupus-Like Disease in MRL/lpr Mice.
    Rohraff DM, He Y, Farkash EA, Schonfeld M, Tsou PS, Sawalha AH.
    Arthritis Rheumatol; 2019 Oct 28; 71(10):1681-1690. PubMed ID: 31106974
    [Abstract] [Full Text] [Related]

  • 19. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
    Ji J, Fan H, Li F, Li X, Dong G, Gong W, Song Y, Liu F, Hua C, Tan R, Dou H, Hou Y.
    Immunol Lett; 2015 Dec 28; 168(2):355-65. PubMed ID: 26545567
    [Abstract] [Full Text] [Related]

  • 20. CSF-1R inhibition attenuates renal and neuropsychiatric disease in murine lupus.
    Chalmers SA, Wen J, Shum J, Doerner J, Herlitz L, Putterman C.
    Clin Immunol; 2017 Dec 28; 185():100-108. PubMed ID: 27570219
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.